Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research
ID: 1744553
The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.
Pharmacogenomics Market(firmenpresse) - According to a new report Global Pharmacogenomics Market, published by KBV research, The Global Pharmacogenomics Market size is expected to reach $9.9 billion by 2025, rising at a market growth of 8.8% CAGR during the forecast period.
The Hospitals and Clinics market dominated the Global Pharmacogenomics Market by End User in 2018, growing at a CAGR of 8.5 % during the forecast period. The Research Institutions market is expected to witness highest CAGR of 9.1% during (2019-2025).
The North America market dominated the Global Infectious Diseases Market by Region in 2018, growing at a CAGR of 9.1 % during the forecast period. The Europe market is expected to witness a CAGR of 9.3% during (2019-2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 11.2% during (2019-2025).
The Sequencing market in the Global Pharmacogenomics Market by Technology would grow at a CAGR of 8 % during the forecast period. The Polymerase Chain Reaction market is expected to witness a CAGR of 8.1% during (2019-2025).
Full Report: https://www.kbvresearch.com/pharmacogenomics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Empire Genomics LLC, Illumina, Inc., oneome LLC, Myriad Genetics Inc., Thermo Fisher Scientific, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Opko Health, Inc., and Becton, Dickinson and Company.
Global Pharmacogenomics Market Segmentation
By Technology
Sequencing
Polymerase Chain Reaction
Electrophoresis
Mass Spectrometry
Microarray
Others
By Application
Oncology
Psychiatry
Infectious Diseases
Neurological Diseases
Pain management
Cardiovascular Diseases
Others
By End User
Hospitals and Clinics
Research Institutions
Academic Institutes
By Geography
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Companies Profiled
Abbott Laboratories
Empire Genomics LLC
Illumina, Inc.
Oneome LLC
Myriad Genetics Inc.
Thermo Fisher Scientific, Inc.
Teva Pharmaceuticals Industries Ltd.
Bayer AG
Opko Health, Inc.
Becton, Dickinson and Company
Unique Offerings from KBV Research
Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free
Pharmacogenomics Market Related Reports:
North America Market
Europe Market
Asia Pacific Market
LAMEA Market
Weitere Infos zu dieser Pressemeldung:
Themen in dieser Pressemitteilung:
pharmacogenomics
pharmacogenomics-market
kbv-research
pharmacogenomics-market-size
pharmacogenomics-market-analysis
pharmacogenomics-market-growth
Unternehmensinformation / Kurzprofil:
KBV Research is Knowledge Based Value Research, which is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals. KBV Research is a global market research and consulting company offering syndicated and custom market research reports with exhaustive industry analysis.
244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)
Tel: +1 (646) 661-6066
Email: info(at)kbvresearch.com
Datum: 13.08.2019 - 14:40 Uhr
Sprache: Deutsch
News-ID 1744553
Anzahl Zeichen: 3750
Kontakt-Informationen:
Ansprechpartner: Prity Singh
Stadt:
New York
Telefon: 6466616066
Kategorie:
Pharma
Meldungsart: Produktinformation
Versandart: Veröffentlichung
Freigabedatum: 13.08.2019
Diese Pressemitteilung wurde bisher 588 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Global Pharmacogenomics Market to reach a market size of $9.9 billion by 2025- KBV Research"
steht unter der journalistisch-redaktionellen Verantwortung von
KBV Research (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
